title: Re: Clinical performance of serum isoform (-2)proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: results from a multicentric European study.
authors.forename: Samir S
authors.initials: SS
authors.lastname: Taneja
mesh_terms: D000367:Age Factors; D001706:Biopsy; D016022:Case-Control Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D020033:Protein Isoforms; D011498:Protein Precursors / Q000097:blood*; D012680:Sensitivity and Specificity
chemical_list: C583834:(-2)pro-prostate-specific antigen, human; D020033:Protein Isoforms; D011498:Protein Precursors; D017430:Prostate-Specific Antigen